Evotec (NASDAQ:EVO) Shares Gap Up – Here’s What Happened

Evotec SE (NASDAQ:EVO)’s stock price gapped up prior to trading on Monday . The stock had previously closed at $4.44, but opened at $4.58. Evotec shares last traded at $4.45, with a volume of 39,766 shares changing hands.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and set a $8.00 target price on shares of Evotec in a research report on Thursday, November 7th.

Evotec Price Performance

The business has a fifty day moving average price of $4.40 and a 200 day moving average price of $4.06. The company has a current ratio of 2.09, a quick ratio of 1.99 and a debt-to-equity ratio of 0.43.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in EVO. BNP Paribas Financial Markets acquired a new stake in shares of Evotec during the 4th quarter worth approximately $27,000. Bank of America Corp DE boosted its stake in Evotec by 262.5% during the fourth quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock worth $53,000 after buying an additional 9,289 shares in the last quarter. CSS LLC IL bought a new stake in Evotec in the 4th quarter valued at $50,000. DCF Advisers LLC raised its stake in shares of Evotec by 5.9% in the 4th quarter. DCF Advisers LLC now owns 229,871 shares of the company’s stock valued at $956,000 after buying an additional 12,816 shares in the last quarter. Finally, Lighthouse Investment Partners LLC bought a new position in shares of Evotec during the 4th quarter worth about $166,000. Institutional investors own 5.81% of the company’s stock.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.